Search
CG Oncology Inc
CGONAdd to Watchlist
75.990USD
+11.190+17.27%
Close 11-06 16:00（ET）
6.74BMarket Cap
LossP/E TTM
CG Oncology Inc (CGON) Stock Price Target & Forecast
Analyst Rating
Based on 15 analysts giving stock ratings to CG Oncology Inc in the past month.
Buy
3 Strong Buy
11 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
90.667USD+40.18%
CGON Analyst Recommendation Trends
In the current month, CGON has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CGON average Analyst price target in the last month is 90.667.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
3
3
3
3
3
11
11
11
12
12
12
12
12
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
15
15
16
16
15
15
15
CGON Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Biontech SE
BNTX
4
12
6
0
0
22
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Financial Forecasting
Based on analysts' estimates, CGON EPS is projected to reach -0.852 in FY2026Q4, following reported EPS of -0.640 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.57
-0.66
-0.84
-0.85
-0.91
Actual
-0.71
-0.90
-0.64
--
--
Surprise
-25.88%
-34.93%
+23.88%
--
--
FAQs
What is CG Oncology Inc's expected revenue for the next quarter?
CG Oncology Inc's expected revenue is 560.00K.
What is CG Oncology Inc's price target?
Analysts forecast that CG Oncology Inc's price target is USD 90.67, with the highest forecast at USD 108.00 and the lowest forecast at USD 79.00.
How have CG Oncology IncCGON's recent earnings per share performed?
The market expectation was USD -0.64, while CG Oncology IncCGON's earnings per share (EPS) for the previous quarter was USD -0.90. EPS for the next quarter is expected at USD -0.85.
What is the analyst rating for CG Oncology Inc?
Based on the ratings of CG Oncology Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.